Chromium nicotinate

DB14529ApprovedSmall moleculeNicotinic Acids

Chromium nicotinate is a medication used to treat chromium deficiencies and associated symptoms and also in total parenteral nutrition.

Chemical structure of Chromium nicotinate
Mechanism
Curator reviewed · 6 references
Primary indication
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.Curator reviewed
Formula / weight
C18H12CrN3O6 · 418.305 g/mol (avg)
First approval
United States, 2015
Also known as
Chromium(III) nicotinate

Resolves to

Clinical / RWD
Structure
InChIKeyMSPQQAUTCRWLGR-UHFFFAOYSA-KSMILES[Cr+3].[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
32Marketed productsAcross 2 countries and 7 labellers
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Chromium nicotinate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account